Agarwal G, Gabrani R (2021) Antiviral peptides: identification and validation. Int J Pept Res Ther 27(1):149–168. https://doi.org/10.1007/s10989-020-10072-0

Article  CAS  PubMed  Google Scholar 

Al-Azzam S, Ding Y, Liu J, Pandya P, Ting JP, Afshar S (2020) Peptides to combat viral infectious diseases. Peptides 134:170402. https://doi.org/10.1016/j.peptides.2020.170402

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amruta N, Engler-Chiurazzi EB, Murray-Brown IC, Gressett TE, Biose IJ, Chastain WH et al (2021) In vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 Transgenic mice. Life Sci 284:119881. https://doi.org/10.1016/j.lfs.2021.119881

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayad R, Keskinkaya HB, Atalar MN, Lefahal M, Zaabat N, Makhloufi EH et al (2023) Jurinea humilis DC. Polar extract: HPLC analysis, photoprotective, antioxidant activities and bioactive content. Chem Afr 6(2):827–836. https://doi.org/10.1007/s42250-022-00525-y

Article  CAS  Google Scholar 

Barreto-Vieira DF, da Silva MN, Garcia CC, Miranda MD, Matos ADR, Caetano BC, Barth OM (2021) Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells. Mem Inst Oswaldo Cruz 116:e200443

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beddingfield BJ, Iwanaga N, Chapagain PP, Zheng W, Roy CJ et al (2021) The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection. Basic Transl Sci 6(1):1–8. https://doi.org/10.1016/j.jacbts.2020.10.003

Article  Google Scholar 

Bhardwaj VK, Singh R, Sharma J, Rajendran V, Purohit R, Kumar S (2021) Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn 39(10):3449–3458. https://doi.org/10.1080/07391102.2020.1766572

Article  CAS  PubMed  Google Scholar 

Bojarska J, Wolf WM (2020) Ultra-short cyclo-peptides as bio-inspired therapeutics: Proline-based 2, 5-diketopiperazines (DKP). MDPI 79(1):10. https://doi.org/10.3390/IECBM2020-08804

Article  Google Scholar 

Bouzidi HS, Driouich JS, Klitting R, Bernadin O, Piorkowski G et al (2024) Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains. Antivir Res 222:105814. https://doi.org/10.1016/j.antiviral.2024.105814

Article  CAS  PubMed  Google Scholar 

Cai Z, Bai H, Ren D, Xue B, Liu Y, Gong T et al (2024) Integrin Αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2. Virus Res 339:199251. https://doi.org/10.1016/j.virusres.2023.199251

Article  CAS  PubMed  Google Scholar 

Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L et al (2020) De Novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science 370(6515):426–431. https://doi.org/10.1126/science.abd9909

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carpino LA, Imazumi H, El-Faham A, Ferrer FJ, Zhang C, Lee Y et al (2002) The uronium/guanidinium peptide coupling reagents: finally, the true uronium salts. Angew Chem Int Ed Engl 41(3):441–445

Article  CAS  PubMed  Google Scholar 

Cheng F, Li W, Liu G, Tang Y (2013) In Silico ADMET prediction: recent advances, current challenges and future trends. Curr Top Med Chem 13(11):1273–1289

Article  CAS  PubMed  Google Scholar 

Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Cohen RB (2006) Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours. Br J Cancer 94(11):1621–1626. https://doi.org/10.1038/sj.bjc.6603171

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke NE, Fisher MJ, Porter KE, Lambert DW, Turner AJ (2012) Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling. PLoS ONE 7(4):e34747. https://doi.org/10.1371/journal.pone.0034747

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coin I, Beyermann M, Bienert M (2007) Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nat Protoc 2(12):3247–3256. https://doi.org/10.1038/nprot.2007.454

Article  CAS  PubMed  Google Scholar 

Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10(1):9–22. https://doi.org/10.1038/nrc2748

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhaliwal D, Shepherd TG (2022) Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review. Clin Exp Metastasis 39(2):291–301. https://doi.org/10.1007/s10585-021-10136-5

Article  CAS  PubMed  Google Scholar 

Dhankhar P, Dalal V, Kumar V (2021) Screening of severe acute respiratory syndrome coronavirus 2 RNA-Dependent RNA polymerase inhibitors using computational approach. J Comput Biol 28(12):1228–1247. https://doi.org/10.1089/cmb.2020.0639

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhankhar P, Dalal V, Singh V, Tomar S, Kumar P (2022) Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2. J Biomo Struct Dyn 40(9):4084–4099. https://doi.org/10.1080/07391102.2020.1852968

Article  CAS  Google Scholar 

Doñate F, Parry GC, Shaked Y, Hensley H, Guan X, Beck I, Mazar AP (2008) Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-Shaped Dose-Response curve in several preclinical models of angiogenesis and tumor growth. Clin Cancer Res 14(7):2137–2144. https://doi.org/10.1158/1078-0432.CCR-07-4530

Article  PubMed  Google Scholar 

Eda SR, Pakala S, Ummanni R, Amineni U, Jinka R (2024) Novel peptide design and evaluation against actin and α5β1integrin. Res Sq. https://doi.org/10.21203/rs.3.rs-4003076/v1

Article  Google Scholar 

Erckes V, Steuer C (2022) A story of peptides, lipophilicity and chromatography - back and forth in time. RSC Med Chem 13(6):676–687. https://doi.org/10.1039/D2MD00027J

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feixiong C, Weihua L, Guixia L, Yun T (2013) In Silico ADMET Prediction: Recent Advances, Current Challenges and Future Trends. Curr Top Med Chem 13(11):1273–1289. https://doi.org/10.2174/15680266113139990033

Article  Google Scholar 

Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122–128. https://doi.org/10.1016/j.drudis.2014.10.003

Article  CAS  PubMed  Google Scholar 

Hillary VE, Ceasar SA (2023) An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines. Heliyon 9(3):e13952–e13952. https://doi.org/10.1016/j.heliyon.2023.e13952

Article  PubMed  PubMed Central  Google Scholar 

Huang M, Pan X, Wang X, Ren Q, Tong B, Dong X, Chen J (2023) Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2. Signal Transduct Target Ther 8(1):84. https://doi.org/10.1038/s41392-023-01348-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huntington KE, Carlsen L, So EY, Piesche M, Liang O, El-Deiry WS (2022) Integrin/TGF-β1 inhibitor GLPG-0187 blocks SARS-CoV-2 delta and omicron pseudovirus infection of airway epithelial cells in vitro, which could attenuate disease severity. Pharmaceuticals 15(5):618. https://doi.org/10.3390/ph15050618

Article  CAS  PubMed  PubMed Central